News Article

For all the political friction, the PLFSS debate performs a useful function: it tells investors precisely where the state believes the system can no longer keep spending as before.

In this timely piece by Candesic Senior partner Marc Kitten and Engagement Manager Dr Marco Mazavet, read how the current impasse highlights deep divisions at the highest level over fiscal discipline, healthcare reforms and pharmaceutical policy.

Click to download our report to read about

✅Proposals to slash “overly profitable” sectors

✅Digital health record requirements

✅Introducing caps on pharmacy discounts

✅The next steps in this ongoing battle

Click button below to download.